Researchers are exploring the use of RNA therapeutics for in vivo CAR-macrophage, which may advance cardiac immunotherapy. This approach is being investigated as a potential treatment. The development of this therapy is reportedly underway, with a focus on its potential to improve cardiac health through immunotherapy.